Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
APILAM informs you that the personal data that you provide to us by filling in this form will be treated by APILAM as responsible for this web.
The purpose of the collection and processing of personal data that we request is to manage the registration of this subscription and send periodic bulletins with information and prospective offer of products or services.
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Last update July 31, 2014
Mequitazine
High Risk
Poorly safe. Evaluate carefully.
Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives).
Read the Comment.
Second generation antihistaminic and phenothiazine drug with a sedative effect.
Follow-up for sedation and feeding ability of the infant.
Bed-sharing is not recommended for mothers who are taking this medication.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
UNICEF UK Baby Friendly Initiative statement on Bed-sharing when parents do not smoke: is there a risk of SIDS? An individual level analysis of five major case-control studies.None2013Full text (link to original source)Full text (in our servers)
L.Landa Rivera, M.Díaz-Gómez, A.Gómez Papi, J.M.Paricio Talayero, C.Pallás Alonso, M.T.Hernández Aguilar, J.Aguayo Maldonado, J.M.Arena Ansotegui, S.Ares Segura, A.Jiménez Moya, J.J.Lasarte Velillas, J.Martín Calama, M.D.Romero Escós. El colecho favorece la práctica de la lactancia materna y no aumenta el riesgo de muerte súbita del lactante. Dormir con los padres.Rev Pediatr Aten Primaria. 14:53-602012Full text (link to original source)Full text (in our servers)
ABM - Comité de protocolos de la Academia médica de lactancia materna (Academy of Breastfeeding Medicine). Protocolo Clínico de la ABM #6: Lineamientos sobre la práctica de dormir al bebé junto con la madre y la lactancia materna Revisión, marzo de 2008.Breastfeeding Medicine2008Full text (link to original source)Full text (in our servers)
UNICEF UK. Compartiendo la cama con tu bebé. Guía para madres que amamantan.Folleto2006Full text (in our servers)
Total visits
4,596
Help us improve this entry
How to cite this entry
Do you need more information or did not found what you were looking for?
Second generation antihistaminic and phenothiazine drug with a sedative effect.
Follow-up for sedation and feeding ability of the infant.
Bed-sharing is not recommended for mothers who are taking this medication.